O
OrbusNeich
A global pioneer in the development of life-changing vascular solutions
About OrbusNeich
OrbusNeich is a global leader in the design, development, manufacturing, and marketing of innovative medical devices aimed at treating vascular diseases. The company primarily serves healthcare providers, including hospitals and specialized medical centers, that focus on cardiovascular treatments. Operating in the medical device industry, OrbusNeich's core products include advanced stents and balloon catheters, which are essential for procedures like angioplasty and percutaneous coronary intervention (PCI).
The business model revolves around the continuous innovation and improvement of its product line to meet the evolving needs of the cardiovascular healthcare sector. Revenue is generated through the direct sale of these medical devices to healthcare institutions worldwide. OrbusNeich has a strong presence in key markets, including Asia, Europe, and the Americas, and has received regulatory approvals in multiple countries, enhancing its market reach and credibility.
Key products like the COMBO Dual Therapy Stent and Sapphire II PRO balloons are designed to improve patient outcomes by reducing complications such as stent thrombosis. The company's commitment to research and development ensures that it remains at the forefront of medical technology, offering solutions that address both current and future healthcare challenges.
Source: Dealroom company dataNews
Open roles
OrbusNeich in the Sha Tin District ecosystem
The OrbusNeich office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Shenzhen Capital Group- GGGalaxy Finance Holding Group
CICC
CCB International- CSChina Merchants Securities
Share Capital
Series B and later1 investor entered at this stage
- HMHangzhou Fuyang Industrial Fund Investment Management
Source: Dealroom Talent Intelligence.
Patents
90 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See OrbusNeich on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

